<DOC>
	<DOCNO>NCT02590510</DOCNO>
	<brief_summary>The main purpose study compare effect 10 mg 15 mg methotrexate treatment meningeal carcinomatosis .</brief_summary>
	<brief_title>Different Dose Methotrexate Treatment Meningeal Carcinomatosis</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Meningeal Carcinomatosis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>age 14 history solid tumor new clinical neurological sign symptom typical CT ( Computerized Tomography , CT ) MRI ( Magnetic Resonance Imaging , MRI ) image finding tumor cell cerebrospinal fluid KPS score &lt; 60 tumor patient organ failure bacteria , fungi viral meningitis</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Intrathecal chemotherapy</keyword>
</DOC>